REDWOOD CITY, Calif., March 23, 2023 Rezolute, Inc. , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment. | March 23, 2023
RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-VEGF) injections into the eyeREDWOOD CITY, Calif., March 23, 2023 (GLOBE NEWSWIRE) Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceuti.
Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.